Heart, Lung and Circulation
Volume 18, Issue 1 , Pages 19-27 , February 2009

Advances in Coronary Microvascular Dysfunction

  • John F. Beltrame, FRACP, PhD, FESC, FACC, FCSANZ

      Affiliations

    • Cardiology Unit, The Queen Elizabeth Hospital, Lyell McEwin Health Service, University of Adelaide, Adelaide, Australia
    • Corresponding Author InformationCorresponding author at: Cardiology Unit, The Queen Elizabeth Hospital, 28 Woodville Rd, Woodville South, SA 5011, Australia. Tel.: +61 8 8222 7632; fax: +61 8 8222 6624.
    • ,
  • Filippo Crea, FESC, FACC

      Affiliations

    • Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
    • ,
  • Paolo Camici, FESC, FACC, FAHA, FRCP

      Affiliations

    • Clinical Sciences Centre & NHLI, Imperial College, Hammersmith Campus, London, United Kingdom

References 

  1. Australian Institute of Health & Welfare. Heart, stroke and vascular disease—Australian facts 2004, vol. AIHW cat no. CVD-27. Canberra: AIHW and National Heart Foundation of Australia; 2004.
  2. Beltrame JF, Tavella R, Weekes A, Morgan C. Persistent Angina Symptoms in Stable Angina Patients: The Coronary Artery Disease in gENeral practiCE (CADENCE). In Heart, Lung, and Circ. 2008;17(Suppl 3):S100
  3. Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis: instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol. 1974;33:87–94
  4. Maseri A. The coronary circulation. In: Ischemic heart disease. A rational basis for clinical practice and clinical research, vol. 4, 1st ed. New York: Churchill Livingstone; 1995. p. 71–104.
  5. Kaufmann PA, Camici PG. Myocardial blood flow measurement by PET: technical aspects and clinical applications. J Nucl Med. 2005;46:75–88
  6. Toyota E, Koshida R, Hattan N. Regulation of the coronary vasomotor tone: what we know and where we need to go. J Nucl Cardiol. 2001;8:599–605
  7. Muller JM, Davis MJ, Chilian WM. Integrated regulation of pressure and flow in the coronary microcirculation. Cardiovasc Res. 1996;32:668–678
  8. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356:830–840
  9. Dayanikli F, Grambow D, Muzik O, Mosca L, Rubenfire M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation. 1994;90:808–817
  10. Kaufmann PA, Gnecchi-Ruscone T, Schafers KP, Luscher TF. Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol. 2000;36:103–109
  11. Yokoyama I, Momomura S, Ohtake T, Yonekura K, Nishikawa J, Sasaki Y. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1997;30:1472–1477
  12. Di Carli MF, Janisse J, Grunberger G, Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol. 2003;41:1387–1393
  13. Laine H, Raitakari OT, Niinikoski H, Pitkanen OP, Iida H, Viikari J, et al. Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol. 1998;32:147–153
  14. Kaufmann PA, Gnecchi-Ruscone T, di Terlizzi M, Schafers KP, Luscher TF. Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation. 2000;102:1233–1238
  15. Likoff W, Segal BL, Kasparian H. Paradox of normal selective coronary arteriograms in patients considered to have unmistakable coronary heart disease. N Engl J Med. 1967;276:1063–1066
  16. Beltrame JF. Chest pain and normal angiography. In: Braunwald E, editor. Braunwald's heart disease edition, vol. 2006. Philadelphia: Elsevier; 2006: date added: 28 March at www.braunwalds.com.
  17. Arbogast R, Bourassa MG. Myocardial function during atrial pacing in patients with angina and normal arteriograms. Am J Cardiol. 1973;32:257–263
  18. Kemp HG, Vokonas PS, Cohn PF, Gorlin R. The anginal syndrome associated with normal coronary arteriograms. Am J Med. 1973;54:735–742
  19. Botker HE, Moller N, Ovesen P, Mengel A, Schmitz O, Orskov H, et al. Insulin resistance in microvascular angina (syndrome X). Lancet. 1993;342:136–140
  20. Maseri A. Syndrome X and microvascular angina. In:  Maseri A editors. Ischemic heart disease. A rational basis for clinical practice and clinical research. New York: Churchill Livingstone; 1995;p. 507–532
  21. Kaski JC. Cardiac syndrome X and microvascular angina. In:  Kaski JC editors. Chest pain with normal coronary angiograms: pathogenesis, diagnosis and management. London: Kluwer Academic Publishers; 1999;p. 1–12
  22. Cannon RO, Watson RM, Rosing DR, Epstein SE. Angina caused by reduced coronary vasodilator reserve of the small coronary arteries. J Am Coll Cardiol. 1983;1:1359–1373
  23. Epstein SE, Cannon RO, Bonow RO. Exercise testing in patients with microvascular angina. Circulation. 1991;83:III73–III76
  24. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries: a new angiographic finding. Am Heart J. 1972;84:66–71
  25. Mangieri E, Macchiarelli G, Ciavolella M, Barilla F, Avella A, Martinotti A, et al. Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn. 1996;37:375–381
  26. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small-vessel coronary artery disease in patients with angina and patent large coronary arteries. Circulation. 1986;74:964–972
  27. Beltrame JF, Limaye SB, Wuttke R, Horowitz JD. Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon. Am Heart J. 2003;146:84–90
  28. Beltrame JF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon—a new coronary microvascular disorder. Cardiology. 2002;97:197–202
  29. Lucarini AR, Picano E, Salvetti A. Coronary microvascular disease in hypertensives. Clin Exp Hypertens A. 1992;14:55–66
  30. Yang EH, Yeo TC, Higano ST, Nishimura RA, Lerman A. Coronary hemodynamics in patients with symptomatic hypertrophic cardiomyopathy. Am J Cardiol. 2004;94:685–687
  31. Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med. 2003;349:1027–1035
  32. Kume T, Akasaka T, Kawamoto T, Yoshitani H, Watanabe N, Neishi Y, et al. Assessment of coronary microcirculation in patients with takotsubo-like left ventricular dysfunction. Circ J. 2005;69:934–939
  33. Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K, Yamanaka T, et al. Coronary flow reserve in patients with dilated cardiomyopathy. Am Heart J. 1993;125(1):93–98
  34. Al Suwaidi J, Velianou JL, Gertz MA, Cannon RO 3rd, Higano ST, Holmes DR, et al. Systemic amyloidosis presenting with angina pectoris. Ann Intern Med. 1999;131:838–841
  35. Elliott PM, Kindler H, Shah JS, Sachdev B, Rimoldi O, Thaman R, et al. Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase A. Heart. 2006;92(March(3)):357–360
  36. Julius BK, Spillmann M, Vassalli G, Villari B, Eberli FR, Hess OM. Angina pectoris in patients with aortic stenosis and normal coronary arteries. Mechanisms and pathophysiological concepts. Circulation. 1997;95:892–898
  37. Nemes A, Forster T, Csanady M. Coronary flow reserve increases after successful aortic valve replacement in patients with hemodynamically significant aortic stenosis and normal coronary angiogram. J Am Coll Cardiol. 2002;9(Suppl B):256B
  38. Sun H, Mohri M, Shimokawa H, Usui M, Urakami L, Takeshita A. Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. J Am Coll Cardiol. 2002;39:847–851
  39. Marzilli M, Sambuceti G, Testa R, Fedele S. Platelet glycoprotein IIb/IIIa receptor blockade and coronary resistance in unstable angina. J Am Coll Cardiol. 2002;40:2102–2109
  40. Gregorini L, Marco J, Kozakova M, Palombo C, Anguissola GB, Marco I, et al. Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation. 1999;99:482–490
  41. Uren NG, Crake T, Lefroy DC, De Silva R, Davies GJ, Maseri A. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med. 1994;331:222–227
  42. Gregorini L, Marco J, Palombo C, Kozakova M, Anguissola GB, Cassagneau B, et al. Postischemic left ventricular dysfunction is abolished by alpha-adrenergic blocking agents. J Am Coll Cardiol. 1998;31:992–1001
  43. Pupita G, Maseri A, Kaski JC, Galassi AR, Gavrielides S, Davies G, et al. Myocardial ischemia caused by distal coronary-artery constriction in stable angina pectoris. N Engl J Med. 1990;323:514–520
  44. Sambuceti G, Parodi O, Marcassa C, Neglia D, Salvadori P, Giorgetti A, et al. Alteration in regulation of myocardial blood flow in one-vessel coronary artery disease determined by positron emission tomography. Am J Cardiol. 1993;72:538–543
  45. Uren NG, Crake T, Lefroy DC, DeSilva R, Davies GJ, Maseri A. Delayed recovery of coronary resistive vessel function after coronary angioplasty. J Am Coll Cardiol. 1993;21:612–621
  46. Spyrou N, Khan MA, Rosen SD, Foale R, Davies DW, Sogliani F, et al. Persistent but reversible coronary microvascular dysfunction after bypass grafting. Am J Physiol Heart Circ Physiol. 2000;279:H2634–H2640
  47. Abbate A, Kontos MC, Biondi-Zoccai GG. No-reflow: the next challenge in treatment of ST-elevation acute myocardial infarction. Eur Heart J. 2008;29(Aug(15)):1795–1797
  48. Shimokawa H, Yasuda S. Myocardial ischemia: current concepts and future perspectives. J Cardiol. 2008;52:67–78
  49. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002;346:1948–1953
  50. Galassi A, Crea F, Araujo L, Lammertsma A, Pupita G, Yamamoto Y, et al. Comparison of regional myocardial blood flow in syndrome X and one-vessel coronary artery disease. Am J Cardiol. 1993;72:134–139
  51. Bottcher M, Botker HE, Sonne H, Nielsen T, Czernin J. Endothelium-dependent and -independent perfusion reserve and the effect of l-arginine on myocardial perfusion in patients with syndrome X. Circulation. 1999;99:1795–1801
  52. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelial-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med. 1993;328:1659–1664
  53. Chauhan A, Mullins PA, Taylor G, Petch MC, Schofield PM. Both endothelium-dependent and endothelium-independent function is impaired in patients with angina pectoris and normal coronary angiograms. Eur Heart J. 1997;18:60–68
  54. Camici P, Marraccini P, Lorenzoni R, Buzzigoli G, Pecori N, Perissinotto A, et al. Coronary hemodynamics and myocardial metabolism in patients with syndrome X: response to pacing stress. J Am Coll Cardiol. 1991;17:1461–1470
  55. Camici PG, Gistri R, Lorenzoni R, Sorace O, Michelassi C, Bongiorni MG, et al. Coronary reserve and exercise ECG in patients with chest pain and normal coronary angiograms. Circulation. 1992;86:179–186
  56. Rosen SD, Uren NG, Kaski JC, Tousoulis D, Davies GJ, Camici PG. Coronary vasodilator reserve, pain perception, and sex in patients with syndrome X. Circulation. 1994;90:50–60
  57. Camici PG. Is the chest pain in cardiac syndrome X due to subendocardial ischaemia?. Eur Heart J. 2007;28:1539–1540
  58. Beltrame JF. Advances in understanding the mechanisms of angina pectoris in cardiac syndrome X. Eur Heart J. 2005;26:946–948
  59. Rosen SD, Paulesu E, Wise RJ, Camici PG. Central neural contribution to the perception of chest pain in cardiac syndrome X. Heart. 2002;87:513–519
  60. Lanza GA, Colonna G, Pasceri V, Maseri A: Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol 1999;84:854–6, A858.
  61. Chen JW, Lee WL, Hsu NW, Lin SJ, Ting CT, Wang SP, et al. Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina. Am J Cardiol. 1997;80:32–38
  62. Nalbantgil S, Altintigbreve A, Yilmaz H, Nalbantgil II, Onder R. The effect of trimetazidine in the treatment of microvascular angina. Int J Angiol. 1999;8:40–43
  63. Beltrame JF, Turner SP, Leslie SL, Solomon P, Freedman SB, Horowitz JD. The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon. J Am Coll Cardiol. 2004;44:57–62
  64. Mohri M, Shimokawa H, Hirakawa Y, Masumoto A, Takeshita A. Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. J Am Coll Cardiol. 2003;41:15–19
  65. Kurtoglu N, Akcay A, Dindar I. Usefulness of oral dipyridamole therapy for angiographic slow coronary artery flow. Am J Cardiol. 2001;87:777–779
  66. Leslie S, Beltrame JF. A randomised, double-blind, placebo-controlled, crossover study assessing the anti-anginal efficacy of dipyridamole in the coronary slow flow phenomenon. Heart Lung Circ 2005;14:S81.
  67. Lagerqvist B, Sylven C, Waldenstrom A. Lower threshold for adenosine-induced chest pain in patients with angina and normal coronary angiograms. Br Heart J. 1992;68:282–285
  68. Maseri A, Crea F, Kaski JC, Crake T. Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol. 1991;17:499–506
  69. Elliott PM, Krzyzowska-Dickinson K, Calvino R, Hann C, Kaski JC. Effect of oral aminophylline in patients with angina and normal coronary arteriograms (cardiac syndrome X). Heart. 1997;77:523–526
  70. Lanza GA, Gaspardone A, Pasceri V, Perino M, Colonna G, Tomai F, et al. Effects of bamiphylline on exercise testing in patients with syndrome X. G Ital Cardiol. 1997;27:50–54
  71. Chen JW, Hsu NW, Wu TC, Lin SJ, Chang MS. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. Am J Cardiol. 2002;90:974–982
  72. Kaski JC, Rosano GC, Gavrielides S, Chen L. Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina. J Am Coll Cardiol. 1994;23:652–657
  73. Botker HE, Sonne HS, Schmitz O, Nielsen TT. Effects of doxazosin on exercise-induced angina pectoris, ST-segment depression, and insulin sensitivity in patients with syndrome X. Am J Cardiol. 1998;82:1352–1356
  74. Galassi AR, Kaski JC, Pupita G, Vejar M, Crea F, Maseri A. Lack of evidence for alpha-adrenergic receptors-mediated mechanisms in the genesis of ischemia in syndrome X. Am J Cardiol. 1989;64:264–269
  75. Kayikcioglu M, Payzin S, Yavuzgil O, Kultursay H, Can LH, Soydan I. Benefits of statin treatment in cardiac syndrome-X. Eur Heart J. 2003;24:1999–2005
  76. Ghaffari N, Kennedy J, Beltrame JF. Pravastatin inhibits microvascular constrictor responses of phenylephrine and thromboxane analogue, U46619, but not endothelin-1. Heart Lung Circ. 2008;17S:S236
  77. Rosano GM, Peters NS, Lefroy D, Lindsay DC, Sarrel PM, Collins P, et al. 17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X. J Am Coll Cardiol. 1996;28:1500–1505
  78. Cannon RO, Quyyumi AA, Mincemoyer R, Stine AM, Gracely RH, Smith WB, et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med. 1994;330:1411–1417
  79. Lanza GA, Sestito A, Sgueglia GA, Infusino F, Papacci F, Visocchi M, et al. Effect of spinal cord stimulation on spontaneous and stress-induced angina and ‘ischemia-like’ ST-segment depression in patients with cardiac syndrome X. Eur Heart J. 2005;9:9
  80. Cunningham C, Brown S, Kaski JC. Effects of transcendental meditation on symptoms and electrocardiographic changes in patients with cardiac syndrome X. Am J Cardiol 2000;85:653–5, A610.

PII: S1443-9506(08)00947-5

doi: 10.1016/j.hlc.2008.11.002

Heart, Lung and Circulation
Volume 18, Issue 1 , Pages 19-27 , February 2009

Article Tools